Using a new stem-cell based drug screening technology with the potential to reinvent and greatly reduce the cost of the way new pharmaceuticals are developed, Harvard Stem Cell Institute researchers have found a compound more effective in protecting the neurons killed in amyotrophic lateral sclerosis - Lou Gehrig's disease - than two drugs that ... (more)
http://www.medilexicon.com/medicalnews.php?newsid=259363
http://www.medilexicon.com/medicalnews.php?newsid=259363
No comments:
Post a Comment